{"id":818976,"date":"2025-02-27T07:08:40","date_gmt":"2025-02-27T12:08:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/"},"modified":"2025-02-27T07:08:40","modified_gmt":"2025-02-27T12:08:40","slug":"amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/","title":{"rendered":"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PRINCETON, N.J., Feb.  27, 2025  (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt;text-align:justify\">TD Cowen 45<sup>th<\/sup> Annual Health Care Conference in Boston, MA, on Tuesday, March 4, 2025, at 9:50 a.m. ET<\/li>\n<li style=\"text-align:justify\">Leerink Partners 2025 Global Healthcare Conference in Miami, FL, on Monday, March 10, 2025, at 10:00 a.m. ET<\/li>\n<\/ul>\n<p>A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uNPP1oHUtGIwfL6xYBCB8VDSYmIiHDtrguSMa5jFEPTRue6sUm3PYBlSF97b-JZozDedwa6zeRTjwWqr33hWHaeoNXbqyQVjO0oQy5q5e0dY38cNhNQFOVnmFFHXPpcdS8q6sLqwne11q2D83M7O-uUX9ccH_hJuuizOJ3wR9cg=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.amicusrx.com\/events-and-presentations<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About Amicus Therapeutics <\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jVYupsNvgaeSaJ_7D_azFCu5lGkZfB2PKhp7j-Xc8iNCYUxXRgyDzFkGC9gzHQAnPg3FjvTYNZsbMupvExOIMw==\" rel=\"nofollow\" target=\"_blank\">www.amicusrx.com<\/a>, and follow on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZKQQle6-aBAPPb9qcqpqeiA2djy_b1rzKY2FOz3_8_r8oszhYpp28INOQH9OF-Q7\" rel=\"nofollow\" target=\"_blank\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IXpfq_L6BPkWhNg_ojLVz73G1wXf7NUdpxZMhCuJSAIPSjoys_zlYjU5ezne3LCVtrJPdNhPgjD7ksv_sobi_hhJUt6iwu-wV8G0xfauzOBoqOM6-NUTj0ZZ1TSac5nI\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">CONTACT:<\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Amicus Therapeutics<br \/>Andrew Faughnan<br \/>Vice President, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wHTh6cQA_wY7mZox8Wik0F2HqO4WscZWeQGqfmP3pLLqQGTTUW_rBO0qF2Mv_wgNkepmapYiAemKOpP8lcqxd95GUGzHuGh6oWZwtKx4TCc=\" rel=\"nofollow\" target=\"_blank\">afaughnan@amicusrx.com<\/a><br \/>(609) 662-3809<\/p>\n<p align=\"justify\">\n        <strong>Media:<\/strong><br \/>\n        <br \/>Amicus Therapeutics<br \/>Diana Moore<br \/>Head of Global Corporate Affairs and Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i38pvYjs6WbUg7hKpfrG1cnVuPNHhLSmzean0d8gJ_GZ2fSRLGJheXr5VbuFbisU24ZsDZRAOFnqYwZ-59CL4XsI9DMf_pkuRln6WS7oaO8=\" rel=\"nofollow\" target=\"_blank\">dmoore@amicusrx.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ysPRvuZ7tGfkbtJtiHnRBk9pMU3i1pblX4D-tzXnLqkGm22x6KoMLS7djwz4kYu1-EMxBxpvXqed1I2LF-bUTw==\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a>(609) 662-5079<\/p>\n<p align=\"justify\">FOLD\u2013G<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmJjZjM3NGMtNTU3Ni00N2Q4LTg3ZmQtNDU4ZDBiY2UwNjE2LTEwMTcyMzE=\/tiny\/Amicus-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. TD Cowen 45th Annual Health Care Conference in Boston, MA, on Tuesday, March 4, 2025, at 9:50 a.m. ET Leerink Partners 2025 Global Healthcare Conference in Miami, FL, on Monday, March 10, 2025, at 10:00 a.m. ET A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https:\/\/ir.amicusrx.com\/events-and-presentations. About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-818976","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. TD Cowen 45th Annual Health Care Conference in Boston, MA, on Tuesday, March 4, 2025, at 9:50 a.m. ET Leerink Partners 2025 Global Healthcare Conference in Miami, FL, on Monday, March 10, 2025, at 10:00 a.m. ET A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https:\/\/ir.amicusrx.com\/events-and-presentations. About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, &hellip; Continue reading &quot;Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-27T12:08:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025\",\"datePublished\":\"2025-02-27T12:08:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/\"},\"wordCount\":194,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/\",\"name\":\"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=\",\"datePublished\":\"2025-02-27T12:08:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/","og_locale":"en_US","og_type":"article","og_title":"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Market Newsdesk","og_description":"PRINCETON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. TD Cowen 45th Annual Health Care Conference in Boston, MA, on Tuesday, March 4, 2025, at 9:50 a.m. ET Leerink Partners 2025 Global Healthcare Conference in Miami, FL, on Monday, March 10, 2025, at 10:00 a.m. ET A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https:\/\/ir.amicusrx.com\/events-and-presentations. About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, &hellip; Continue reading \"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-27T12:08:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025","datePublished":"2025-02-27T12:08:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/"},"wordCount":194,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/","name":"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=","datePublished":"2025-02-27T12:08:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NTczOCM2NzgxNjYxIzIwMDU2NTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-present-at-upcoming-investor-conferences-in-march-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/818976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=818976"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/818976\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=818976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=818976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=818976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}